EGFR and squamous cell carcinoma: The specific targeting of the EGFR typically expressed at high levels on squamous cell carcinoma by using biocompatible anti-EGFR-antibody and FITC tagged silica nanoparticles is a promising approach for contrast enhancement and could foster the use of confocal endomicroscopy in head and neck oncology.